Lipum AB (publ) (LIPUM.ST)

SEK 13.3

(-1.48%)

Long Term Debt Summary of Lipum AB (publ)

  • Lipum AB (publ)'s latest annual long term debt in 2023 was 1.76 Million SEK , up 6.02% from previous year.
  • Lipum AB (publ)'s latest quarterly long term debt in 2024 Q1 was 1.76 Million SEK , down 0.0% from previous quarter.
  • Lipum AB (publ) reported annual long term debt of 1.66 Million SEK in 2022, up 6.07% from previous year.
  • Lipum AB (publ) reported annual long term debt of 1.56 Million SEK in 2021, up 6.06% from previous year.
  • Lipum AB (publ) reported quarterly long term debt of 1.76 Million SEK for 2024 Q2, down 0.0% from previous quarter.
  • Lipum AB (publ) reported quarterly long term debt of 1.76 Million SEK for 2024 Q1, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Lipum AB (publ) (2023 - 2017)

Historical Annual Long Term Debt of Lipum AB (publ) (2023 - 2017)

Year Long Term Debt Long Term Debt Growth
2023 1.76 Million SEK 6.02%
2022 1.66 Million SEK 6.07%
2021 1.56 Million SEK 6.06%
2020 1.47 Million SEK 0.0%
2019 - SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%

Peer Long Term Debt Comparison of Lipum AB (publ)

Name Long Term Debt Long Term Debt Difference
Alligator Bioscience AB (publ) 7.51 Million SEK 76.57%
Ziccum AB (publ) 286 Thousand SEK -515.734%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 2.15 Million SEK 18.169%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK -107.176%
Genovis AB (publ.) 74.8 Million SEK 97.646%
Intervacc AB (publ) 142 Thousand SEK -1140.141%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Active Biotech AB (publ) 3 Million SEK 41.3%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 94.595%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 97.301%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 4.29 Million SEK 59.008%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -315.33%
Egetis Therapeutics AB (publ) 103.4 Million SEK 98.297%
Karolinska Development AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -76.1%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 99.813%
Camurus AB (publ) 13.61 Million SEK 87.064%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 92.815%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 844.9 Million SEK 99.792%
Cyxone AB (publ) 74 Thousand SEK -2279.73%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK -22.632%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 94.488%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -1194.853%
SynAct Pharma AB 58 Thousand SEK -2936.207%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -107.176%
LIDDS AB (publ) - SEK -Infinity%
BioInvent International AB (publ) 14.53 Million SEK 87.884%
Alzinova AB (publ) 800 Thousand SEK -120.125%
Oncopeptides AB (publ) 106.48 Million SEK 98.346%
Pila Pharma AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 98.059%
Diamyd Medical AB (publ) 30.67 Million SEK 94.259%
Xbrane Biopharma AB (publ) 112.89 Million SEK 98.44%
Ascelia Pharma AB (publ) 176 Thousand SEK -900.568%
Diagonal Bio AB (publ) - SEK -Infinity%